Purchase Order 75D30120P08413
Award Date 6/2/20
Potential Completion Date 8/31/20
Potential Value $155K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Coralville, IA 52241, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $115,346.90 firm fixed-price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Integrated DNA Technologies, Inc. (IDT), a manufacturer of nucleic acid products for the life sciences industry. The contract supports COVID-19 response efforts and is not set aside. IDT has a Federal Supply Schedule contract with the Department of Veterans Affairs to provide oligonucleotides, probes, and custom DNA/RNA synthesized...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Integrated DNA Technologies, Inc. (IDT) for the delivery of primer kits and probe kits. The $154,671.98 contract has a completion date of October 2, 2020 and is associated with the Coronavirus COVID-19 national interest action. IDT, a manufacturer of nucleic acid products, has previously supplied the federal government with a range of goods and services including...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Integrated DNA Technologies, Inc. (IDT) for $16,438.00 in lab supplies. IDT is a manufacturer of nucleic acid products, including custom DNA and RNA oligonucleotides, gene fragments, next generation sequencing products, primers, probes, reagents, and research materials. IDT has held a Federal Supply Schedule contract with the Department of Veterans Affairs valued at...
- This is a $2,425,869.00 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Integrated DNA Technologies, Inc. (IDT), a leading provider of specialized nucleic acid products and services to the U.S. federal government. The contract, which has a period of performance through June 19, 2024, is for the procurement of oligonucleotides. IDT has supported a wide range of federal agencies, including the NIH, CDC, DoD, and Department of Commerce,...
- The Centers for Disease Control and Prevention (CDC) awarded a $249,445 firm-fixed-price purchase order to Integrated DNA Technologies, Inc. (IDT) to provide oligonucleotides and gene production in support of the development of COVID-19 vaccine candidates. The award does not have a set-aside designation. IDT is a major provider of specialized nucleic acid products and services to federal agencies, including the NIH, CDC, DoD, and USDA, through prime contracts and subcontracts. The company...
- This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Integrated DNA Technologies, Inc. (IDT), a manufacturer of nucleic acid products, for the supply of PROBEKITS. The $137,179.84 firm fixed price purchase order does not have a set-aside designation. IDT is a major supplier of oligonucleotides, probes, reagents, and other products to federal agencies like the National Institutes of Health, Department of Defense,...
- Integrated DNA Technologies, Inc. (IDT) has been awarded a firm fixed price purchase order totaling $670,359.20 by the Centers for Disease Control and Prevention (CDC) to provide custom reagents for SARS-CoV-2 genomic sequencing through September 30, 2022. The products will support the CDC's detection and monitoring of COVID-19 variants. No set-aside designation was applied to this procurement. IDT will deliver the reagents from its location in Atlanta, Georgia under the base indefinite...
- This contract was awarded to Integrated DNA Technologies, Inc. (IDT), a leading manufacturer and supplier of specialized nucleic acid products and services to the U.S. federal government. The contract is a Blanket Purchase Agreement (BPA) call with a ceiling value of $14,853.75 and a completion date of September 8, 2014. The funding agency is the Office of the Chief Operating Officer, a civilian agency. IDT has provided custom oligonucleotides, antisense oligonucleotides, DNA library kits, exome...
- This is a firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Integrated DNA Technologies, Inc. (IDT) for the delivery of primers and probes. The contract, valued at $90,225.60, has a period of performance ending on March 13, 2020. IDT is a leading provider of specialized nucleic acid products and services to various federal agencies, including the CDC, supporting biomedical research, pandemic response, and public health initiatives. This award is...
- This federal contract award was made by the Centers for Disease Control and Prevention (CDC) to Integrated DNA Technologies, Inc. (IDT), a leading provider of specialized nucleic acid products and services to the U.S. government. The $214,978.20 firm-fixed-price purchase order is for "RAPID OLIGO AND DNA" products and services, which likely includes custom DNA and RNA oligonucleotides, gene fragments, primers, probes, and other reagents to support the CDC's biomedical research,...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Firm Fixed Price Purchase Order to Integrated DNA Technologies, Inc. (IDT), a manufacturer of nucleic acid products, on June 2, 2020. The $154,671.98 contract supports COVID-19 response efforts and has a completion date of August 31, 2020. IDT, a for-profit organization, has an active Federal Supply Schedule contract with the Department of Veterans Affairs to provide oligonucleotides, probes, and custom DNA/RNA synthesized products in support of patient care and research. This indefinite delivery/indefinite quantity contract has a potential value of $2.5 million.
Generated 3/21/24, 5:37 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | $0 | 8/31/20 | |
| Not listed | Not listed | $154.7k | 6/2/20 |